基于 DNA 超分子水凝胶的保护性 NK 细胞储库用于增强三阴性乳腺癌治疗
Protective NK Cell Reservoir Based on DNA Supramolecular Hydrogel for Enhanced Triple-Negative Breast Cancer Therapy.
过继性自然杀伤(NK)细胞疗法是治疗三阴性乳腺癌的一种有前景的策略,但其疗效往往受到瘤内持久性差以及在免疫抑制性肿瘤微环境中功能耗竭的限制。
英文原题:Core Needle Biopsies as an Alternative Source for Ex Vivo Expanded TIL for Adoptive Cell Therapy in Triple-Negative Breast Cancer.
我们评估了从CNB获取的原发性三阴性乳腺癌肿瘤中产生和扩增TIL的能力(n=7),并证明经phorbol myristate acetate-ionomycin刺激后,其扩增、表型和细胞因子分泌与从手术标本扩增的TIL相当(n=6)。
体外扩增TIL(肿瘤浸润淋巴细胞)后进行过继输注,已使转移性癌症患者获得长期应答。传统上,TIL从手术切除标本中扩增。超声引导下粗针活检(CNB)是另一种取材方式,可避免手术相关损伤,并可能使不适合手术的患者也能参与;此外,还可能从同一患者多个病灶制备TIL。本研究评估从原发性三阴性乳腺癌(TNBC)CNB标本中制备和扩增TIL的能力。研究从7例CNB标本扩增TIL,并发现经佛波醇肉豆蔻酸乙酸酯-离子霉素刺激后,其扩增能力、表型和细胞因子分泌与从6例手术标本扩增的TIL相当。两个队列在TIL培养过程中T细胞受体克隆性和多样性也相近。CNB是一种安全可行的取材方法,可为TNBC患者制备TIL。
Adoptive transfer of ex vivo expanded tumor-infiltrating lymphocytes (TILs) have produced long-term response in metastatic cancers. TILs have traditionally been expanded from surgically resected specimens. Ultrasound-guided core needle biopsy (CNB) is an alternative method that avoids the morbidity of surgery and have added benefits which may include patients not amenable to surgery as well as the potential to produce TILs from multiple lesions in the same patient. We assessed the ability to produce and expand TILs from primary triple-negative breast cancer tumors from CNB (n=7) and demonstrate comparable expansion, phenotype and cytokine secretion after phorbol myristate acetate-ionomycin stimulation to TILs expanded from surgery (n=6). T cell Receptor clonality and diversity were also comparable between the two cohorts throughout the TIL culture. CNB is a safe and feasible method to obtain tumor tissue for TIL generation in patients with triple-negative breast cancer.
MEMBER ACCOUNT
登录成功会直接打开下一页。